SHR-1918

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NameSHR-1918
Drug Alias NameSHR-1918SHR1918
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAngiopoietin like 3 inhibitors
TargetsAngiopoietin like 3
Therapy Area/IndicationsHomozygous familial hypercholesterolemiaHypertriglyceridemiaHypercholesterolemia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesBeijing Suncadia Medicine Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Tuojie Biomedical Technology Co LtdBeijing Suncadia Medicine Co LtdFujian Suncadia Medicine Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsHomozygous familial hypercholesterolemiaHypertriglyceridemiaHypercholesterolemia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A